Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis

Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis

Leila Gobejishvili,1 Walter E Rodriguez,1 Philip Bauer,2 Yali Wang,1 Chirag Soni,2 Todd Lydic,3 Shirish Barve,1 Craig McClain,1 Claudio Maldonado4 1Department of Medicine, School of Medicine, University of Louisville, Louisville, KY, USA; 2Endoprotech, Inc., Louisville, KY, USA; 3Lipidomics Center,...

Full description

Bibliographic Details
Main Authors: Gobejishvili L, Rodriguez WE, Bauer P, Wang Y, Soni C, Lydic T, Barve S, McClain C, Maldonado C
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Drug Design, Development and Therapy
Subjects:
liposomes
rolipram
side-effects
pde4
liver
Online Access:https://www.dovepress.com/novel-liposomal-rolipram-formulation-for-clinical-application-to-reduc-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/novel-liposomal-rolipram-formulation-for-clinical-application-to-reduc-peer-reviewed-fulltext-article-DDDT

Similar Items